Results 101 to 110 of about 12,232 (185)
A narrative review of PCSK9 inhibitors: from evolocumab to novel discoveries. [PDF]
Front PharmacolLiu HH, Li S, Li JJ.
europepmc +1 more source
Enzyme-Assisted Synthesis and In Vitro Characterization of Bifunctional PCSK9 Inhibitors. [PDF]
ChembiochemZhang Y +8 more
europepmc +1 more source
PCSK9 Inhibitors Reduce Oxidative Stress Biomarkers in Heterozygous Familial Hypercholesterolemia. [PDF]
J Cell Mol MedWoźniak-Szczepocka A +5 more
europepmc +1 more source
Adherence to PCSK9 Inhibitors in Clinical Practice: Systematic Review and Meta-Analysis of Observational Studies. [PDF]
JACC AdvBlais JE +4 more
europepmc +1 more source
Novel Approaches to Lipid Management: Beyond Statins and PCSK9 Inhibitors. [PDF]
J Clin Med ResPatel J +5 more
europepmc +1 more source
Role of PCSK9 inhibitors in the management of dyslipidaemia
Indian Heart JournalProprotein convertase subtilisin kexin9 (PCSK9) inhibitors are novel agents that lower LDL cholesterol and reduce cardio-vascular event rate. Being expensive, these agents are reserved for those with high risk or very high risk of CV events and with suboptimal response to statins and ezetimibe, with or without bempedoic acid or those intolerant to ...
openaire +3 more sources
Comparative Efficacy of Statins Versus PCSK9 Inhibitors in Coronary Heart Disease Treatment. [PDF]
J Am Heart AssocYu L +5 more
europepmc +1 more source
PCSK9 inhibitors conquer primary prevention: the VESALIUS-CV study. [PDF]
Eur Heart J SupplGatto L +4 more
europepmc +1 more source